Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue International Journal of Drug Policy Année : 2017

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses

Fichier non déposé

Dates et versions

hal-03480040 , version 1 (14-12-2021)

Identifiants

Citer

Jv Lazarus, K Safreed-Harmon, Sr Stumo, Marie Jauffret-Roustide, M Maticic, et al.. Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses. International Journal of Drug Policy, 2017, 47 (Suppl. C), pp.47-50. ⟨10.1016/j.drugpo.2017.05.054⟩. ⟨hal-03480040⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More